Angioimmunoblastic T-cell lymphoma and myelodysplastic syndrome with mutations in TET2, DNMT3 and CUX1 - azacitidine induces only lymphoma remission

被引：9

作者：

Tobiasson, Magnus ^{[1
,2
]}

Pandzic, Tatjana ^{[3
]}

Cavelier, Lucia ^{[3
]}

Sander, Birgitta ^{[2
,4
]}

Wahlin, Bjoern Engelbrekt ^{[1
,2
]}

机构：

[1] Karolinska Inst, Dept Hematol, Stockholm, Sweden

[2] Karolinska Univ Hosp, Stockholm, Sweden

[3] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden

[4] Karolinska Inst, Div Pathol, Dept Lab Med, Stockholm, Sweden

来源：

LEUKEMIA & LYMPHOMA | 2019年 / 60卷 / 13期

关键词：

5-AZACYTIDINE; EFFICACY; MDS;

D O I：

10.1080/10428194.2019.1627541

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3316 / 3319

页数：4

共 50 条

[1] TET2 and DNMT3A Mutations in Human T-Cell Lymphoma
Couronne, Lucile
Bastard, Christian
Bernard, Olivier A.
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (01): : 95 - 96
[2] TET2 mutations in B cells of patients affected by angioimmunoblastic T-cell lymphoma
Schwartz, Friederike H.
Cai, Qian
Fellmann, Eva
Hartmann, Sylvia
Mayranpaa, Mikko I.
Karjalainen-Lindsberg, Marja-Liisa
Sundstrom, Christer
Scholtysik, Rene
Hansmann, Martin-Leo
Kueppers, Ralf
JOURNAL OF PATHOLOGY, 2017, 242 (02): : 129 - 133
[3] A Targeted Mutational Landscape of Angioimmunoblastic T-Cell Lymphoma: Association Between Advanced Age and Mutations in TET2 and DNMT3A
Weigert, Oliver
Kopp, Nadja
Bolla, Sudha
Odejide, Oreofe
Toscano, Dan
Lunning, Matthew A.
Teruya-Feldstein, Julie
Louissaint, Abner
Rodig, Scott J.
Horwitz, Steven M.
Weinstock, David
BLOOD, 2012, 120 (21)
[4] Role of Tet2 and RHOAG17V mutations in Angioimmunoblastic T-cell lymphoma
Nguyen, Tran B.
Yanagimoto, Mamiko Sakata
Fujisawa, Manabu
Chiba, Shigeru
CANCER SCIENCE, 2018, 109 : 179 - 179
[5] Targeting TET2 as a Therapeutic Approach for Angioimmunoblastic T Cell Lymphoma
Hu, Lina
Zhang, Xuanye
Li, Huifeng
Lin, Suxia
Zang, Shengbing
CANCERS, 2022, 14 (22)
[6] Angioimmunoblastic T-cell Lymphoma Contains Multiple Clonal T-cell Populations Derived from a Common Progenitor Cell Carrying TET2 Mutations
Yao, W. Q.
Wu, F.
Zhang, W.
Thompson, J. S.
Zhang, S. W.
Clipson, A.
Wang, M.
Liu, H.
Bibawi, H.
Grant, J. W.
Wright, P.
El-Daly, H.
Raso-Barnett, L.
Farkas, L.
Gao, Z.
Chuang, S. S.
Ashton-Key, M.
Liu, W.
Du, M. Q.
JOURNAL OF PATHOLOGY, 2019, 248 : S5 - S5
[7] Double somatic mosaic mutations in TET2 and DNMT3A-origin of peripheral T cell lymphoma in a case
Nguyen, Tran B.
Sakata-Yanagimoto, Mamiko
Nakamoto-Matsubara, Rie
Enami, Terukazu
Ito, Yufu
Kobayashi, Toshikata
Obara, Naoshi
Hasegawa, Yuichi
Chiba, Shigeru
ANNALS OF HEMATOLOGY, 2015, 94 (07) : 1221 - 1223
[8] Double somatic mosaic mutations in TET2 and DNMT3A—origin of peripheral T cell lymphoma in a case
Tran B. Nguyen
Mamiko Sakata-Yanagimoto
Rie Nakamoto-Matsubara
Terukazu Enami
Yufu Ito
Toshikata Kobayashi
Naoshi Obara
Yuichi Hasegawa
Shigeru Chiba
Annals of Hematology, 2015, 94 : 1221 - 1223
[9] TET2 Mutation in Adult T-Cell Leukemia/Lymphoma
Shimoda, Kazuya
Shide, Kotaro
Kameda, Takuro
Hidaka, Tomonori
Kubuki, Yoko
Kamiunten, Ayako
Sekine, Masaaki
Akizuki, Keiichi
Shimoda, Haruko
Yamaji, Takumi
Nakamura, Kenichi
Abe, Hiroo
Miike, Tadashi
Iwakiri, Hisayoshi
Tahara, Yoshihiro
Sueta, Mitsue
Yamamoto, Shojiro
Hasuike, Satoru
Nagata, Kenji
Kitanaka, Akira
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2015, 55 (03) : 145 - 149
[10] Efficacy of 5-Azacytidine in a TET2 mutated angioimmunoblastic T cell lymphoma
Cheminant, Morgane
Bruneau, Julie
Kosmider, Olivier
Lefrere, Francois
Delarue, Richard
Gaulard, Philippe
Radford, Isabelle
Derrieux, Coralie
Hermine, Olivier
Lemonnier, Francois
BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (06) : 913 - 916

← 1 2 3 4 5 →